HFpEF as the predominant and underrecognized heart failure phenotype in type 2 diabetes: evidence from the DIABET-IC study
HFpEF is the most frequent HF phenotype in the T2D population, with outcomes comparable to HFrEF yet frequently underdiagnosed and undertreated. Improved screening strategies and broader adoption of evidence-based therapies-particularly SGLT2 inhibitors-are urgently needed for this high-risk population.
Authors
- Javier Muñiz (ORCID: https://orcid.org/0000-0002-3087-2067)
- Vivencio Barrios (ORCID: https://orcid.org/0000-0001-6135-7685)
- Antonio Pérez (ORCID: https://orcid.org/0000-0001-5528-1143)
- Pedro Gil (ORCID: https://orcid.org/0000-0003-3707-7450)
- José Antonio Gimeno-Orna (ORCID: https://orcid.org/0000-0002-9901-4992)
- Luis Rodrı́guez Padial (ORCID: https://orcid.org/0000-0002-5783-3922)
- Manuel Anguita
Institutions
- Universidade da Coruña (ES)
- Universitat Autònoma de Barcelona (ES)
- Instituto Cajal (ES)
- Hospital de Sant Pau (ES)
- ProMedica Toledo Hospital (US)
- Hospital Universitario Reina Sofía (ES)
- Vall d'Hebron Hospital Universitari (ES)
- Hospital Clínico Universitario Lozano Blesa (ES)
- Complejo Hospitalario Universitario de Toledo (ES)
Publication Details
- Journal
- Cardiovascular Diabetology
- Published
- 2025-11-03
- DOI
- https://doi.org/10.1186/s12933-025-02995-z
- Citations
- 1
- Primary Topic
- Diabetes Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 1.29
Funders
- Sociedad Española de Cardiología